Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation.
[Contribution of cerebral magnetic resonance imaging to etiological investigation of uveitis.]
MULTIPLE SCLEROSIS IN CHILDHOOD.
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis.
Acquired Immunologic Neuropathies.
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Remyelination therapy goes to trial for multiple sclerosis.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
Experimental autoimmune encephalomyelitis.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
P2X4 receptors control the fate and survival of activated microglia.
Pages
« first
‹ previous
…
650
651
652
653
654
655
656
657
658
…
next ›
last »